BioPharma Credit Investments (BPCR) Ord
BioPharma Credit Plc is a closed-ended investment company. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly holds an interest in royalty rights to certain products, including any investment vehicle or special purpose vehicle. The Company's un-invested capital may be invested in cash instruments or bank deposits for cash management purposes. The Company may, from time to time, enter into such hedging or other derivative arrangements. The Company's investment manager is Pharmakon Advisors L.P.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.